Who is sponsoring NCT02593058?

NCT02593058 is sponsored by Institut et Haute Ecole de la Santé la Source.

What drugs are being tested in NCT02593058?

Interventions in NCT02593058: Positive Emotions Program for Schizophrenia, Treatment As Usual.

What condition does NCT02593058 study?

NCT02593058 studies Schizophrenia, Schizoaffective Disorder.

Is NCT02593058 still recruiting?

NCT02593058 is currently completed. Last updated 25 March 2019.

Last reviewed 2019-03-25 · How we verify

NCT02593058: PEPS-RCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Positive Emotions Program for Schizophrenia (PEPS)

Completed NA Last updated 25 March 2019

What this trial tests

NA trial testing Positive Emotions Program for Schizophrenia in Schizophrenia in 80 participants. Completed in 31 December 2018.

Timeline

1 February 2016

Primary endpoint
31 December 2017

31 December 2018

Quick facts

Lead sponsor	Institut et Haute Ecole de la Santé la Source
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	80
Start date	1 February 2016
Primary completion	31 December 2017
Estimated completion	31 December 2018
Sites	1 location across Switzerland

Drugs / interventions tested

Positive Emotions Program for Schizophrenia
Treatment As Usual

Conditions studied

Schizophrenia — all drugs for Schizophrenia →
Schizoaffective Disorder — all drugs for Schizoaffective Disorder →

Sponsor

Institut et Haute Ecole de la Santé la Source

Who can join

Adults 18 to 65, any sex, with Schizophrenia or Schizoaffective Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the addition of a 8 session psychological program, called Positive Emotions Program for Schizophrenia (PEPS) to improve motivation and pleasure in adults with schizophrenia. Half of the participants will receive their usual treatment and PEPS in combination, while the other half will receive usual treatment only.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial.
Favrod J, Nguyen A, Chaix J, Pellet J, et al · · 2019 · cited 39× · PMID 30783071 · DOI 10.1159/000496479

Verify or expand the search:

Other recruiting trials for Schizophrenia

Currently open trials in the same condition.

NCT07424404 — A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au · Phase 3 · recruiting
NCT07467993 — Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia · Phase 2 · recruiting
NCT07379827 — Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) · recruiting
NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting

Other Institut et Haute Ecole de la Santé la Source trials

Trials by the same sponsor.

NCT07068009 — Training and Support Programme on Data-driven Quality Development for Swiss Long-Term Care Facilities (NIP-Q-UPGRADE Sub · NA · active not recruiting
NCT06035770 — The Effectiveness of Mental Health First Aid Intervention Among Undergraduate Students in Switzerland · NA · completed
NCT04020497 — Ensemble Programme an Early Intervention for Informal Caregivers of Psychiatric Patients · NA · unknown
NCT03283891 — Effects on Nurses' Quality of Working Life of an Educational Intervention to Strengthen Their Humanistic Practice · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02593058 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut et Haute Ecole de la Santé la Source
Last refreshed: 25 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02593058.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing